Loike J D
Cancer Chemother Pharmacol. 1982;7(2-3):103-11. doi: 10.1007/BF00254530.
VP16-213, a semi-synthetic derivative of podophyllotoxin, is an effective antitumor agent in the treatment of a variety of leukemias and solid tumors. A comparison of the mechanism of action of VP16-213 and podophyllotoxin has revealed that although both drugs inhibit the uptake of nucleosides into HeLa cells, they exhibit other biological properties which are quite distinct. Podophyllotoxin is a potent inhibitor of microtubule assembly in vitro, while VP16-213 has no effect in this system. VP16-213 induces single stranded breaks in HeLa cells DNA, an effect which may be related to its antitumor activity. In contrast to VP16-213 treated cells, podophyllotoxin-treated cells maintain DNA integrity. Structure-activity relationship studies have identified some of chemical sites of VP16-213 and podophyllotoxin responsible for each of their biological properties. These studies illustrate that chemical modification of podophyllotoxin can generate derivatives which possess new and unique biological properties.
VP16 - 213是鬼臼毒素的半合成衍生物,是治疗多种白血病和实体瘤的有效抗肿瘤药物。对VP16 - 213和鬼臼毒素作用机制的比较表明,尽管两种药物都抑制核苷进入HeLa细胞的摄取,但它们表现出其他截然不同的生物学特性。鬼臼毒素在体外是微管组装的强效抑制剂,而VP16 - 213在该系统中无作用。VP16 - 213诱导HeLa细胞DNA单链断裂,这一效应可能与其抗肿瘤活性有关。与VP16 - 213处理的细胞相反,鬼臼毒素处理的细胞保持DNA完整性。构效关系研究已经确定了VP16 - 213和鬼臼毒素各自生物学特性所涉及的一些化学位点。这些研究表明,鬼臼毒素的化学修饰可以产生具有新的独特生物学特性的衍生物。